NERV

NASDAQStock

Minerva Neurosciences, Inc.

$7.84+0.15 (+1.95%)

52-Week Range

$1.34

$8.00

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

-0.30

Volume

191.8K

Avg Volume

210.7K

Performance

+22.26%

+90.35%

+241.78%

YTD

+96.17%

+399.35%

+341.95%

-71.05%

Price Chart

ETF Exposure

NERV is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
STSB	iShares Factors US Small Blend Style ETF	0.02%	750	$1K	$7.3M	0.35%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	8	$46	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	302	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	1	$8	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	172,045	$699K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	904	$5K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	78	$428	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	51,013	$207K	$84.10B	0.05%

About NERV ETF Exposure

Minerva Neurosciences, Inc. (NERV) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $7.84. Investors can gain exposure to NERV through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NERV, sorted by portfolio weight.